HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

An unusual variant of prostatic adenocarcinoma with metastasis to testis. A case report.

Abstract
Ductal adenocarcinoma of the prostate is considered to be a rare variant of prostatic adenocarcinoma when compared to the more common acinar adenocarcinoma. We report here a case of ductal adenocarcinoma of the prostate in a 68-year old man who presented with complaints of abdominal pain, retention of urine and hematuria of one month duration. Clinical examination showed prostatomegaly. The serum Prostate Specific Antigen (PSA) value was raised to 79ng/mL. Histopathological and immunohistochemical evaluation of resected specimen of prostate revealed ductal adenocarcinoma of the prostate. The patient was lost to follow up and presented four years after the initial diagnosis with metastasis to the bone and testis. Though prostatic cancers have the ability for wide spread dissemination, metastasis to testis is rare. Immunohistochemical staining with PSA and Prostatic Acid Phosphatase (PAP) can help in establishing prostatic nature of the neoplasm. We are reporting this case because of the rarity of metastasis of prostatic carcinoma to testis and for stressing the need for keeping in mind the possibility of metastatic carcinoma also while dealing with testicular tumors.
AuthorsK R Anila, T Somanathan, A Mathews, K Jayasree
JournalThe Gulf journal of oncology (Gulf J Oncolog) Issue 12 Pg. 73-6 (Jul 2012) ISSN: 2078-2101 [Print] Kuwait
PMID22773221 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Acid Phosphatase
  • prostatic acid phosphatase
  • Protein Tyrosine Phosphatases
  • Prostate-Specific Antigen
Topics
  • Acid Phosphatase
  • Adenocarcinoma (blood, pathology)
  • Aged
  • Humans
  • Male
  • Prostate-Specific Antigen (analysis)
  • Prostatic Neoplasms (blood, pathology)
  • Protein Tyrosine Phosphatases (blood)
  • Testicular Neoplasms (secondary)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: